Department of Emergency Medicine, Department of Internal Medicine, Virginia Commonwealth University Health System, Richmond, VA 23298, United States.
BerbeeWalsh Department of Emergency Medicine, University of Wisconsin-Madison, Madison, WI 53705, United States.
Am J Emerg Med. 2021 Sep;47:80-85. doi: 10.1016/j.ajem.2021.03.057. Epub 2021 Mar 22.
Early antibiotics are fundamental to sepsis management. Second-dose antibiotic delays were associated with increased mortality in a recent study. Study objectives include: 1) determine factors associated with delays in second-dose antibiotic administration; 2) evaluate if delays influence clinical outcomes.
ED-treated adults (≥18 years; n = 1075) with severe sepsis or septic shock receiving ≥2 doses of intravenous antibiotics were assessed, retrospectively, for second-dose antibiotic delays (dose time > 25% of recommended interval). Predictors of delay and impact on outcomes were determined, controlling for MEDS score, 30 mL/kg fluids and antibiotics within three hours of sepsis onset, lactate, and renal failure, among others.
In total, 335 (31.2%) patients had delayed second-dose antibiotics. A total of 1864 second-dose antibiotics were included, with 354 (19.0%) delays identified by interval (delayed/total doses): 6-h (36/67) = 53.7%; 8-h (165/544) = 30.3%; 12-h (114/436) = 26.1%; 24-h (21/190) = 8.2%; 48-h (0/16) = 0%. In-hospital mortality in the timely group was 15.5% (shock-17.6%) and 13.7% in the delayed group (shock-16.9%). Increased odds of delay were observed for ED boarding (OR 2.54, 95% 1.81-3.55), shorter dosing intervals (6/8-h- OR 2.99, 95% CI 1.95-4.57; 12-h- OR 2.46, 95% CI 1.72-3.51), receiving 30 mL/kg fluids by three hours (OR 1.42, 95% CI 1.06-1.90), and renal failure (OR 2.57, 95% CI 1.50-4.39). Delays were not associated with increased mortality (OR 0.87, 95% CI 0.58-1.29) or other outcomes.
Factors associated with delayed second-dose antibiotics include ED boarding, antibiotics requiring more frequent dosing, receiving 30 mL/kg fluid, and renal failure. Delays in second-dose administration were not associated with mortality or other outcomes.
早期使用抗生素是脓毒症治疗的关键。最近的一项研究表明,第二剂抗生素的延迟使用与死亡率的增加有关。本研究的目的包括:1)确定导致第二剂抗生素延迟使用的因素;2)评估延迟是否会影响临床结果。
回顾性评估了在急诊科接受治疗的成年患者(≥18 岁;n=1075),这些患者患有严重脓毒症或脓毒性休克,并接受了≥2 剂静脉内抗生素治疗,评估了第二剂抗生素延迟使用(给药时间超过推荐间隔的 25%)。确定了延迟的预测因素及其对结局的影响,控制了 MEDS 评分、3 小时内给予 30 mL/kg 液体和抗生素、乳酸和肾功能衰竭等因素。
共有 335 例(31.2%)患者的第二剂抗生素延迟使用。总共纳入了 1864 剂第二剂抗生素,通过间隔确定了 354 例(19.0%)延迟:6 小时(36/67)=53.7%;8 小时(165/544)=30.3%;12 小时(114/436)=26.1%;24 小时(21/190)=8.2%;48 小时(0/16)=0%。及时组的院内死亡率为 15.5%(休克-17.6%),延迟组为 13.7%(休克-16.9%)。观察到延迟的可能性更高的因素包括急诊科留观(OR 2.54,95%置信区间 1.81-3.55)、较短的给药间隔(6/8 小时-OR 2.99,95%置信区间 1.95-4.57;12 小时-OR 2.46,95%置信区间 1.72-3.51)、3 小时内给予 30 mL/kg 液体(OR 1.42,95%置信区间 1.06-1.90)和肾功能衰竭(OR 2.57,95%置信区间 1.50-4.39)。延迟与死亡率增加(OR 0.87,95%置信区间 0.58-1.29)或其他结局无关。
导致第二剂抗生素延迟使用的因素包括急诊科留观、需要更频繁给药的抗生素、给予 30 mL/kg 液体和肾功能衰竭。第二剂给药的延迟与死亡率或其他结局无关。